You can buy or sell SIGA and other stocks, options, ETFs, and crypto commission-free!
SIGA Technologies, Inc. engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. Read More It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded on December 28, 1995 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
Yahoo FinanceFeb 21
SIGA to Present at the 8th Annual SVB Leerink Global Healthcare Conference on March 1, 2019
NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L. Gomez, SIGA’s Chief Executive Officer, will present at the 8th Annual SVB Leerink Global Healthcare Conference at 9:00 am ET on Friday, March 1, 2019 in New York. To access the live webcast and a copy of the presentation, please visit the Investor Relations section of the Company’s website, under Events & Pr...
Expected May 3, After Hours